Cirsium Biosciences
PrivateLast Round
Grant
Sep 23, 2024
Est. Valuation
$26M
Total Funding Raised
$61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cirsium Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in September 2024.
Cirsium Biosciences is a biotechnology company that develops a plant-based manufacturing platform for the production of viral vectors used in gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirsium Biosciences Comparables
Compare Cirsium Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KBio Inc. | 74% | |
| CHA Biotech Co. Ltd | 72% | |
| Baiya Phytopharm | 71% |
For institutional investors. Book with your work email.
Cirsium Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2024 | ||||
| VC Round | Jun 11, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cirsium Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARPA-H | Grant |
| KdT Ventures | VC Round |
| Insight Partners | VC Round |
| PhiFund Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 84% MoM.
For institutional investors. Book with your work email.
Cirsium Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cirsium Biosciences's valuation, stock price, and market status.
Is Cirsium Biosciences a public or private company?
Cirsium Biosciences is a private company.
What is the current stock price of Cirsium Biosciences?
Cirsium Biosciences is a private company, so its shares have no public market price. Caplight tracks Cirsium Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cirsium Biosciences worth (valuation)?
Cirsium Biosciences's valuation is estimated at $26.0M based on funding round data.
Can I buy Cirsium Biosciences stock?
Cirsium Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cirsium Biosciences's last funding round?
Cirsium Biosciences's most recent funding round was Grant on September 23, 2024.
Who are the main investors in Cirsium Biosciences?
Key investors in Cirsium Biosciences include ARPA-H, KdT Ventures, Insight Partners, PhiFund Ventures.
Will Cirsium Biosciences IPO soon?
No public IPO plans have been announced for Cirsium Biosciences.
How can I track Cirsium Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Cirsium Biosciences's shares on secondary markets.